T. Köşeci, “Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel”, Med Sci Discov, vol. 8, no. 12, pp. 730–734, Dec. 2021.